-The Indian Express Prime Minister Narendra Modi wants doctors to prescribe generic medicines over branded ones. KAUNAIN SHERIFF M answers key questions on the pricing of drugs and beyond. * What exactly has Prime Minister Narendra Modi said on generic drugs? Speaking in Surat on April 17, the Prime Minister referred to the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), which aims to provide cheaper medical drugs to the people. “In the coming days,...
More »SEARCH RESULT
Total Matching Records found : 791
The great Finance Bill trick -Niranjan Sahoo
-DNA The political funding reforms are an embarrassment to India’s claims of heralding a transparency revolution Following Prime Minister Narendra Modi’s demonetization drive and his expressed desire to bring transparency in political funding, there were expectations of more concrete measures to cleanse the Augean stables of Indian politics. The government responded quickly, albeit through the Finance Bill. For the first time, the Union Budget 2017 devoted a full section (420...
More »The high price of Big Pharma greed -Leena Menghaney
-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...
More »Overpriced stents: NPPA issues notice to two hospitals -Sushmi Dey
-The Times of India NEW DELHI: Promptly addressing complaints against hospitals that were allegedly overcharging for stents, the National Pharmaceutical Pricing Authority (NPPA) has issued show-cause notices to Max Hospital, Saket (New Delhi), and Nidaan Hospital, Sonipat (Haryana). While the regulator said that the action is based on the findings of its preliminary investigation, both the hospitals denied the charge and maintained that they have "not overcharged a single patient" for stents. On...
More »NPPA puts price cap on cardiac stents; says hospitals overcharge -Kundan Pandey
-Down to Earth The average cost of drug eluting stent for domestic companies is around Rs 8,000 but it is sold to patients for Rs 24,000 to Rs 1.5 lakh In a decision that will benefit thousands of people in the country, the National Pharmaceutical Pricing Authority (NPPA) has finally put a ceiling on prices of cardiac stent—a small mesh tube that's used to treat narrow or weak arteries. Cardiac stents...
More »
